semaglutide and tirzepatide Wondering about the difference between Tirzepatide? 🤔 Here's a quick breakdown! ✨Semaglutide: A powerful GLP-1 receptor agonist that helps control blood sugar and promotes weight loss. Proven to be effective Tirzepatide versus Semaglutide Once Weekly

Tirzepatide offers dual agonist activity, targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may contribute to its enhanced weight loss efficacy compared to single-receptor agonists

The American Diabetes Association (ADA) recommends it as a first-line therapy for type 2 diabetes patients at high risk of cardiovascular disease, and it is already widely prescribed for metabolic dysfunction-associated steatohepatitis (MASH) and chronic kidney disease, as well as blood glucose and obesity management

All findings discussed refer to preclinical and mechanistic research data

Follow-ups on a monthly basis were conducted for two years after treatment to confirm the regimens effectiveness, and no new lesions were reported for at least six months after the initial three-year treatment regimen

Lilly continues to study the long-term effects of these medicines and works closely with healthcare professionals and people living with obesity to support their safe and appropriate use." What Happens Next The study's authors recommend that guidelines be reviewed so that patients receiving the medications are made aware of the likelihood of rapid weight regain unless the medication is sustained long-term